Group 1 - In the first half of 2025, Chinese companies listed in the US demonstrated strong resilience amidst global market fluctuations, characterized by diverse industry development, balanced regional distribution, and a counter-trend increase in fundraising amounts [2][10] - A total of 45 Chinese companies successfully went public in the US, accounting for 22% of the US IPO market, significantly surpassing the 30 companies from the same period last year [3] Group 2 - The industry distribution of Chinese companies going public in the US shows that 37.21% are in the industrial and service sectors, followed by technology at 23% and consumer at 19%, indicating a shift towards a more diversified international presence [5] - The fundraising situation revealed that approximately $870 million was raised by Chinese companies in the US, with 71% of companies raising less than $10 million, while only 5% raised over $100 million, indicating a polarization in fundraising scales [7] Group 3 - The regional distribution indicates that 18 out of 40 Chinese companies are from Hong Kong, making up 45% of the total, followed by Zhejiang with 4 companies, and Guangdong and Fujian with 3 each, reflecting the influence of regulatory frameworks on listing locations [8] - Despite uncertainties in the global IPO market, the fundraising scale for Chinese companies increased by 22% year-on-year, representing 5.6% of the total IPO fundraising in the US during the same period, showcasing continued interest from the US market in Chinese enterprises [10] Group 4 - The characteristics of Chinese companies going public in the US in the first half of 2025 highlight the international hub role of Hong Kong and the rise of innovative companies from the mainland, driving market dynamics [11] - Looking ahead, the trend suggests that Chinese companies will continue to seek listing opportunities abroad, providing differentiated investment opportunities despite challenges such as rising regulatory costs and geopolitical risks [11]

Core Insights - The US equity financing market showed a recovery in the first half of the year, with total equity financing (including IPOs and refinancing) amounting to $95 billion, an increase of $12.7 billion or 15.46% compared to the same period last year [1] IPO Market Summary - A total of 198 companies successfully went public in the first half of the year, an increase of 84 companies year-on-year, raising $25.9 billion, which is a growth of 33.72% [1] - The Nasdaq led the IPO market with 157 companies listed, raising $17.632 billion, accounting for 68.05% of the total IPO market [1] - The New York Stock Exchange had 29 IPOs raising $8.179 billion, representing 31.57% of the total [1] - The American Stock Exchange (AMEX) had 12 IPOs with a total fundraising of $0.098 billion [1] Refinancing Market Summary - There were 429 refinancing events, a decrease of 17 events compared to last year, with a total refinancing amount of $69.1 billion, an increase of 9.83% [1] - The highest refinancing amount was from Charles Schwab, totaling $13.111 billion, followed by Keurig Dr Pepper at $4.903 billion and QXO at $4.222 billion [2] Notable Companies in IPOs - Venture Global, the second-largest LNG producer in the US, was the top IPO fundraiser with $1.75 billion [2] - CoreWeave and SailPoint Parent raised $1.5 billion and $1.38 billion, respectively, ranking second and third [2] - The top ten IPOs raised a total of $9.7 billion, accounting for 37.62% of the total IPO fundraising [2] SPAC Market Insights - The number of SPAC listings significantly increased, with 52 SPACs going public, up by 40 from the previous year, raising $9.4 billion, a substantial increase of 338.60% [2] Chinese Companies in the US Market - 40 Chinese companies went public in the US, primarily small and medium-sized enterprises, raising a total of $0.9 billion, a decrease of 61.12% year-on-year [3] - Only two companies, Bawang Tea and Ascentage Pharma, raised over $100 million, with amounts of $0.411 billion and $0.126 billion, respectively [3] Underwriting Performance - Cantor Fitzgerald led the IPO underwriting with $2.828 billion across 15 deals, followed by JPMorgan with $2.234 billion from 13 deals, and Goldman Sachs with $2.213 billion from 15 deals [3] - In refinancing, JPMorgan topped the list with $10.398 billion from 39 deals, followed by Goldman Sachs with $9.913 billion from 32 deals [3]

Group 1: Overall Market Performance - In the first half of the year, US equity financing saw a rebound, totaling $95 billion, an increase of $12.7 billion or 15.46% compared to the same period last year [1] - A total of 198 companies went public through IPOs, raising $25.9 billion, which is a 33.72% increase year-over-year [1] - There were 429 refinancing events, a decrease of 17 from the previous year, with a total refinancing amount of $69.1 billion, up 9.83% year-over-year [1] Group 2: Sector Performance - The non-bank financial sector led in financing, raising a total of $32.9 billion [1] - The software services sector ranked second with $9.7 billion raised [1] - The pharmaceutical and biotechnology sector came in third, raising $7.5 billion [1] Group 3: IPO Market Distribution - Nasdaq remained the leading market for IPOs with 157 companies listed, raising $17.632 billion, accounting for 68.05% of the total IPO market [1] - The New York Stock Exchange had 29 IPOs, raising $8.179 billion, which is 31.57% of the total [1] - The American Stock Exchange (AMEX) had 12 IPOs, raising $0.098 billion [1] Group 4: Top IPOs - Venture Global, the second-largest LNG producer in the US, was the top IPO fundraiser with $1.75 billion [2] - CoreWeave and SailPoint Parent followed with $1.5 billion and $1.38 billion, respectively [2] - The top ten IPOs raised a total of $9.7 billion, representing 37.62% of the total IPO fundraising [2] Group 5: SPAC Performance - The number of SPAC IPOs significantly increased, with 52 SPACs listed, up 40 from the previous year, raising $9.4 billion, a substantial increase of 338.60% [2] Group 6: Chinese Companies in the US Market - In the first half of the year, 40 Chinese companies went public in the US, raising only $0.9 billion, a decrease of 61.12% year-over-year [3] - Only two companies, Bawang Tea and Ascentage Pharma, raised over $100 million, with amounts of $0.411 billion and $0.126 billion, respectively [3] Group 7: Underwriting Performance - Cantor Fitzgerald led the IPO underwriting with $2.828 billion across 15 deals [3] - JPMorgan Chase followed with $2.234 billion from 13 deals, while Goldman Sachs was third with $2.213 billion from 15 deals [3] - In refinancing, JPMorgan Chase also led with $10.398 billion from 39 deals, followed closely by Goldman Sachs with $9.913 billion from 32 deals [3]

为获得合理的IPO估值，中企可对标同类业务的美国公司，或跨行业对标商业规律类似的公 司。 本文为IPO早知道原创 作者｜罗宾 微信公众号｜ipozaozhidao 2023 年 ， 中 国 公 司 在 美 国 新 股 IPO 数 量 占 比 近 25%； 今 年 前 三 季 度 中 企 赴 美 IPO 数 量 （ 同 比 +44%）和募资额（同比+15%）延续上升趋势。最近几个交易日，美股中概股股价及估值快速修复 并震荡；纳斯达克金龙指数（HXC.US）过去一周成交量较今年年中上涨4倍。当下环境对中概股赴 美IPO是否带来新的影响？ 近 日 ， 美 国 投 资 者 关 系 和 媒 体 关 系 咨 询 集 团 Blueshirt Group 亚 洲 区 董 事 总 经 理 （ MD ） Gary Dvorchak对IPO早知道表示，目前美股中概股估值仍远低于同类型美国本土公司，会持续吸引知名 价值投资基金等机构的资金。但就IPO来说，由于后续的美国大选结果及西方传统假期影响，2024 年留给中国企业完成赴美IPO的窗口期很小。 Gary预计，最早到2025年二季度，美股才会迎来规模较大的IPO，中概股也会追随这 ...